Mounjaro 2.5 Mg/0.6ml Kwikpen 4 Doses is a once-weekly injectable medication approved by the FDA for lowering blood sugar in adults with type 2 diabetes. It may assist in weight loss but is not FDA approved for this purpose, working by increasing insulin production and reducing liver sugar production.
Key Features
- Active Ingredient: Tirzepatide
- Dosage Form: Injection (pre-filled pen)
- Administration: Subcutaneous injection
- Frequency: Once weekly
Benefits
- Reduces blood sugar levels
- May assist in weight loss
- Improves insulin sensitivity
- Helps control appetite
Important Information
- Potential risk of thyroid tumors
- Contraindicated in type 1 diabetes
- Requires monitoring for side effects
